The Role of Cavin3 in the Development of Malignant Tumors

Lei Qian,1,2,* Ziqian Zhang,3,* Hongning Cai2 1Hubei University of Medicine, Shiyan, Hubei Province, 442000, People’s Republic of China; 2Department of Hubei Clinical Medical Research Center for Gynecologic Malignancy, Maternal and Child Health Hospital of Hubei Province, Wuhan, People’s Republic of China; 3Department of Hubei Clinical Medical Research Center for Gynecologic Malignancy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hongning Cai, Department of Hubei Clinical Medical Research Center for Gynecologic Malignancy, Maternal and Child Health Hospital of Hubei Province (Women and Children’s Hospital of Hubei Province), No. 745, Wuluo Road, Hongshan District, Wuhan, Hubei Province, 430070, People’s Republic of China, Email [email protected]: Cavin3, also known as PRKCDBP or SRBC, is an important member of the Cavin family. It plays a crucial role in the formation and functional regulation of caveolae while also acting as a tumor suppressor in the occurrence and development of most malignant tumors, primarily regulated by promoter region methylation. This paper systematically reviews the research progress of Cavin3 in breast cancer, lung cancer, gastric cancer, colorectal cancer and gynecological tumors, focusing on the role of Cavin3 in tumor prognosis and its possible regulatory mechanism. Current studies have shown that in breast cancer and lung cancer, Cavin3 can exert anti-tumor effects by inhibiting the PI3K/AKT signaling pathway and participating in DNA damage repair. In gastric cancer, it mainly activates downstream pathways by stabilizing p53, inducing cell cycle arrest and apoptosis. However, the specific role of Cavin3 in other tumor types and its broader regulatory mechanism have not yet been fully clarified and further in-depth research is needed. Future research on Cavin3 may provide new insights and effective strategies for precision diagnosis and treatment of malignant tumors.Keywords: Cavin3, tumor suppressor, biomarker, signaling pathway

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-04-01
Primary Topic
Gyrotron and Vacuum Electronics Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of Cavin3 in the Development of Malignant Tumors

SHILAP Revista de lepidopterología
Gyrotron and Vacuum Electronics Research
article

The Role of Cavin3 in the Development of Malignant Tumors

article en

Abstract

Lei Qian,1,2,* Ziqian Zhang,3,* Hongning Cai2 1Hubei University of Medicine, Shiyan, Hubei Province, 442000, People’s Republic of China; 2Department of Hubei Clinical Medical Research Center for Gynecologic Malignancy, Maternal and Child Health Hospital of Hubei Province, Wuhan, People’s Republic of China; 3Department of Hubei Clinical Medical Research Center for Gynecologic Malignancy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hongning Cai, Department of Hubei Clinical Medical Research Center for Gynecologic Malignancy, Maternal and Child Health Hospital of Hubei Province (Women and Children’s Hospital of Hubei Province), No. 745, Wuluo Road, Hongshan District, Wuhan, Hubei Province, 430070, People’s Republic of China, Email [email protected]: Cavin3, also known as PRKCDBP or SRBC, is an important member of the Cavin family. It plays a crucial role in the formation and functional regulation of caveolae while also acting as a tumor suppressor in the occurrence and development of most malignant tumors, primarily regulated by promoter region methylation. This paper systematically reviews the research progress of Cavin3 in breast cancer, lung cancer, gastric cancer, colorectal cancer and gynecological tumors, focusing on the role of Cavin3 in tumor prognosis and its possible regulatory mechanism. Current studies have shown that in breast cancer and lung cancer, Cavin3 can exert anti-tumor effects by inhibiting the PI3K/AKT signaling pathway and participating in DNA damage repair. In gastric cancer, it mainly activates downstream pathways by stabilizing p53, inducing cell cycle arrest and apoptosis. However, the specific role of Cavin3 in other tumor types and its broader regulatory mechanism have not yet been fully clarified and further in-depth research is needed. Future research on Cavin3 may provide new insights and effective strategies for precision diagnosis and treatment of malignant tumors.Keywords: Cavin3, tumor suppressor, biomarker, signaling pathway

SHILAP Revista de lepidopterología
Good health and well-being
Openalex Percentile: Top 48%
Gyrotron and Vacuum Electronics Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Role of Cavin3 in the Development of Malignant Tumors · SHILAP Revista de lepidopterología (2025) | TGRS Research Map | TGRS